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Loss of Immunohistochemical Reactivity
in Association With Handling-Induced
Dark Neurons in Mouse Brains
Virawudh Soontornniyomkij1 , Rachel C. Chang1,
Benchawanna Soontornniyomkij1, Jan M. Schilling2,3,
Hemal H. Patel2,3, and Dilip V. Jeste1,4
Abstract
The handling-induced dark neuron is a histological artifact observed in brain samples handled before fixation with aldehydes. To
explore associations between dark neurons and immunohistochemical alterations in mouse brains, we examined protein products
encoded by Cav3 (neuronal perikarya/neurites), Rbbp4 (neuronal nuclei), Gfap (astroglia), and Aif1 (microglia) genes in adjacent
tissue sections. Here, dark neurons were incidental findings from our prior project, studying the effects of age and high-fat diet on
metabolic homeostasis in male C57BL/6N mice. Available were brains from 4 study groups: middle-aged/control diet, middle-aged/
high-fat diet, old/control diet, and old/high-fat diet. Young/control diet mice were used as baseline. The hemibrains were
immersion-fixed with paraformaldehyde and paraffin-embedded. In the hippocampal formation, we found negative correlations
between dark neuron hyperbasophilia and immunoreactivity for CAV3, RBBP4, and glial fibrillary acidic protein (GFAP) using
quantitative image analysis. There was no significant difference in dark neuron hyperbasophilia or immunoreactivity for any protein
examined among all groups. In contrast, in the hippocampal fimbria, old age seemed to be associated with higher immunoreactivity
for GFAP and allograft inflammatory factor-1. Our findings suggest that loss of immunohistochemical reactivity for CAV3, RBBP4,
and GFAP in the hippocampal formation is an artifact associated with the occurrence of dark neurons. The unawareness of dark
neurons may lead to misinterpretation of immunohistochemical reactivity alterations.
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Introduction
Artifacts associated with handling of animals can occur in any
step of experimental neuroscience research, including behavioral
testing,1 neuroimaging,2 and tissue collection and processing.3
The handling-induced dark neuron is a common feature among a
variety of histological artifacts observed in brain samples.4 With
hematoxylin and eosin (H&E) or cresyl violet staining, dark
neurons are characterized by the monotonous morphological
pattern of contracted hyperchromatic (hyperbasophilic on
H&E staining) cell bodies and dendrites. The formation of dark
neurons is associated with mechanical handling of fresh brain
samples prior to fixation with aldehydes.4–6
There have been a number of published research articles in
which handling-induced dark neurons were misinterpreted as
evidence of neuronal degeneration.4,5 Therefore, the recogni-
tion of dark neurons, as contrasted with degenerating neurons,
is critical for the valid interpretation of neuropathologic
changes that are identified on the basis of histopathological
assessment.4,5 Of note, it is plausible that the presence of dark
neurons could give rise to alterations in immunohistochemical
reactivity. Nonetheless, to our knowledge, there are no reports
in the literature describing immunohistochemical reactivity
changes in association with handling-induced dark neurons.
In the current study, to explore associations between the
occurrence of handling-induced dark neurons and the
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alterations of immunohistochemical reactivity in the mouse
hippocampal formation, we chose to examine 4 protein mar-
kers: caveolin-3 (CAV3, neuronal perikarya/neurites), retino-
blastoma binding protein-4 chromatin remodeling factor
(RBBP4, also known as RbAp48, neuronal nuclei),7 glial fibril-
lary acidic protein (GFAP, astroglia), and allograft inflamma-
tory factor-1 (AIF1, microglia). We used mouse brains
obtained from our previous project originally aimed to study
the effects of age and long-term high-fat diet exposure on
metabolic homeostasis, in which the presence of dark neurons
was an incidental finding. We hypothesized that dark neuron
hyperbasophilia density would negatively correlate with the
immunoreactivity density of protein markers, particularly neu-
ronal markers.
Materials and Methods
Animals
Male C57BL/6N mice (Taconic Biosciences, Taconic Farms,
Hudson, New York) were used. All the experiments were con-
ducted in accordance with the guidelines of the American Asso-
ciation for the Accreditation of Laboratory Animal Care and
National Research Council’s Guide for the Care and Use of
Laboratory Animals and approved by the University of Califor-
nia San Diego Institutional Animal Care and Use Committee.
Upon the completion of experiments (4-month exposure to either
high-fat diet or control diet), mice were divided into 4 harvest
batches for full necropsy and tissue collection within a period of
3 weeks with order counterbalanced for age/diet groups. Imme-
diately after being removed from the skull, the fresh brains were
bisected midsagittally. The left hemibrains were immersion-
fixed with 4% paraformaldehyde/phosphate-buffered saline
(PBS) at 4C for 72 hours and then stored in 0.4% paraformal-
dehyde/PBS at 4C until being processed for paraffin
embedment.
For neuropathologic examination, hemibrains were avail-
able from 4 age/diet study groups of mice: middle-aged (14-
15 months)/control diet (n ¼ 11), middle-aged/high-fat diet
(n ¼ 6), old (24-25 months)/control diet (n ¼ 9), and old/
high-fat diet (n ¼ 7). To acquire baseline data from mice of
younger age, we used young (3 months)/control diet male
C57BL/6N mice (n ¼ 9). All fresh brains in the baseline
group were harvested in 1 batch and the left hemibrains
were immersion-fixed and processed for paraffin embed-
ment with the same protocols as those used in the study
groups.
For all the left hemibrains (n¼ 33 totally in the study groups
and n ¼ 9 in the baseline group), the paraffin-embedded tissue
blocks were trimmed 500 mm off the medial surface. The first
5-μm-thick section taken was stained with H&E. The following
5-μm-thick sections were immunostained for GFAP, AIF1,
RBBP4, and CAV3 in order. All the parasagittal hemibrain
sections revealed the entire dorsal hippocampal formation and
fimbria, consistent with the levels between 500 and 700 mm
from the midline.8 For each hemibrain, 1 tissue section was
evaluated for each stain.
Chromogenic Immunohistochemistry
Primary antibodies used were directed against CAV3 (mouse
monoclonal clone A-3 specific for an epitope mapping amino
acid residues 3–40 at the N-terminus of mouse CAV3, sc-5310,
1:10 000 dilution; Santa Cruz Biotechnology, Santa Cruz, Cali-
fornia), RBBP4 (mouse monoclonal clone 11G10, GTX70232,
1:40 000 dilution; GeneTex, Irvine, California),7 GFAP (rabbit
polyclonal, Z0334, 1:1000 dilution; Dako, Carpinteria, Califor-
nia), and AIF1 (rabbit polyclonal, 019-19741, 1:1000 dilution;
Wako, Richmond, Virginia).
Tissue sections were deparaffinized with xylene and rehy-
drated through graded ethanol series and water. For RBBP4,
GFAP, and AIF1, antigen retrieval was performed by autoclav-
ing the tissue sections at 121C for 20 minutes with 10 mM
Tris/1 mM EDTA-2Na/0.05% Tween-20 buffer (pH 9) and
then cooling down at room temperature for 20 minutes. The
tissue sections were treated for 30 minutes with 0.3% hydrogen
peroxide/PBS to quench endogenous peroxidase activity,
rinsed in PBS (2 times, 5 minutes each), and incubated for 30
minutes with 2.5% normal horse serum (Vector Laboratories,
Burlingame, California). Following 24-hour incubation with
primary antibodies at 4C, the tissue sections were rinsed in
0.1% Tween-20/PBS (2 times, 5 minutes each) and PBS (5
minutes) and then incubated for 40 minutes at room tempera-
ture with horse anti-mouse or -rabbit immunoglobulin G (IgG)
secondary antibody (ImmPRESS HRP anti-IgG [peroxidase]
polymer detection kits, MP-7402 and MP-7401; Vector
Laboratories). Following washing with 0.1% Tween-20/PBS
(2 times, 5 minutes each) and PBS (5 minutes), the signals
were developed with 3,30-diaminobenzidine (ImmPACT DAB
peroxidase [HRP] substrate, SK-4105; Vector Laboratories) for
5 minutes at room temperature. After washing with water for 5
minutes, the tissue sections were dehydrated through graded
ethanol series, cleared in xylene, and mounted with Cytoseal 60
(Richard-Allan Scientific, Waltham, Massachusetts). For the
negative reagent control, the primary antibody was omitted,
as previously described.9
Quantifications of Dark Neuron Hyperbasophilia
and Immunohistochemical Reactivity
By means of 2-dimensional computer-assisted image analysis,
hyperbasophilia of dark neurons on H&E-stained tissue slides
and immunoreactivity for CAV3, RBBP4, GFAP, and AIF1 on
DAB tissue slides were quantified, as described previously.9,10
In brief, the hemibrain sections were digitally scanned using a
microscope slide scanner (Aperio ScanScope GL; Leica Bio-
systems, Buffalo Grove, Illinois) equipped with a 20 objec-
tive lens. Using Aperio ImageScope software (version
10.2.2.2319), a square of 3000 3000 μm2 covering the dorsal
hippocampal formation and fimbria was extracted from each
hemibrain.
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Using Image-Pro Analyzer software (version 6.3; Media
Cybernetics, Bethesda, Maryland), the hippocampal formation
(excluding the subiculum) and fimbria separately were digi-
tally drawn on each of the extracted images having the same
size and resolution. Because dark neurons were distinctly
hyperbasophilic in comparison with well-preserved neurons,
hyperbasophilia of dark neurons was quantified within the hip-
pocampal formation by setting histogram-based RGB color
segmentation to select the specific hyperbasophilia. This color
segmentation setting was consistently applied to all the hemi-
brains. The hyperbasophilia intensity per unit area (ie, hyper-
basophilia density of dark neurons) was calculated, as
described previously.9
For each of the protein markers examined, histogram-
based RGB color segmentation was set to select the specific
immunoreactivity signal and consistently applied to all the
hemibrains. The signal intensity per unit area (ie, signal
density) was calculated, as described previously.9 To adjust
Figure 1. Representative images of the left dorsal hippocampal formation from 2 middle-aged (14-15 months) male C57BL/6N mice (in columns
of adjacent tissue sections, original scan 20). On hematoxylin and eosin staining, (A) dark neurons having contracted hyperbasophilic cell bodies
and dendrites are shown in the stratum pyramidale (between arrows), in comparison with (B) well-preserved neurons. On diaminobenzidine
immunohistochemistry for (C, D) caveolin-3 (CAV3, neuronal perikarya/neurites, with hematoxylin counterstaining), (E, F) retinoblastoma
binding protein-4 chromatin remodeling factor (RBBP4, neuronal nuclei), (G, H) glial fibrillary acidic protein (GFAP, astroglia), and (I, J) allograft
inflammatory factor-1 (AIF1, microglia), focal loss of immunoreactivity for CAV3, RBBP4, and GFAP is observed in a pattern that spatially matches
the presence of dark neurons, whereas the variation of AIF1 immunoreactivity is not conspicuous. Insets¼ high magnification (original scan40).
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for the between-batch variation, 1 brain section from the
same positive tissue control block was included in each
immunostaining batch. The control signal density value (in
a specified neuroanatomic area) was used to normalize all
the signal density values of studied samples in the same
batch, generating the immunoreactivity density values.
Statistical Analysis
The assumption of normality was tested using the Shapiro-
Wilk test for the hyperbasophilia density of dark neurons
(W ¼ 0.750, P < .0001), the immunoreactivity density of
CAV3, RBBP4, GFAP, and AIF1 (W ¼ 0.924, 0.865, 0.940,
and 0.977; P ¼ .008, .0002, .029, and .536, respectively) in
the hippocampal formation, and the immunoreactivity den-
sity of GFAP and AIF1 (W ¼ 0.946 and 0.887, P ¼ .045
and .0006, respectively) in the hippocampal fimbria.
Because the normality assumption could not be confirmed
for all variables except AIF1 in the hippocampal formation,
nonparametric methods were used for all analyses. Spear-
man rho was used to test correlations between the hyperba-
sophilia density of dark neurons and the immunoreactivity
density of each protein marker. The Kruskal-Wallis test was
used to compare the hyperbasophilia density of dark neu-
rons and the immunoreactivity density of each protein mar-
ker across all 5 age/diet mouse groups (4 study and 1
baseline groups). Post hoc comparison procedures were
conducted using the Dunn multiple comparison test. Two-
sided P values of less than .05 were considered statistically
significant. The statistical analyses were performed using
GraphPad Prism (version 6.0h; GraphPad Software, San
Diego, California).
Results
Presence of Dark Neurons on H&E Histopathology
On H&E-stained histopathologic examination, we observed
dark neurons of varying density as an incidental finding in
a high proportion of mouse hemibrains in the study and
baseline groups. In the hippocampal formation (Figure 1),
dark neurons were more conspicuous in the stratum pyrami-
dale than in the stratum granulosum. There was no consis-
tent difference in the distribution of dark neurons across the
hippocampal subfields. No definite changes in the number
or morphology of astroglia or microglia were observed in
spatial relation to the presence of dark neurons in the hip-
pocampal formation of any hemibrains examined. In the
cerebral cortex of all mice in the study and baseline groups,
dark neurons were frequently observed at least in the super-
ficial layers. The hippocampal fimbria white matter showed
no significant histopathologic changes. Thalamic mineral
deposits11 were observed in one of the old/control diet
mice.
Figure 1. (continued).
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Figure 2. Scatter plots showing the relationship between the hyperbasophilia density of dark neurons and the immunoreactivity density of each
protein marker in the left dorsal hippocampal formation. The negative correlation is observed for (A) caveolin-3 (CAV3; r ¼ 0.444, P ¼ .0032),
(B) retinoblastoma binding protein-4 chromatin remodeling factor (RBBP4; r¼0.614, P < .0001), and (C) glial fibrillary acidic protein (GFAP; r¼
0.527, P ¼ .0003) but not statistically significant for (D) allograft inflammatory factor-1 (AIF1; r ¼ 0.246, P ¼ .116; n ¼ 42, Spearman rho).
Table 1. The Hyperbasophilia Density of Dark Neurons and the Immunoreactivity Density of Protein Markers in the Hippocampal Formation by
Age/Diet Mouse Groups.a
Dark Neurons CAV3 RBBP4 GFAP AIF1
Baseline group
Young/control diet group (n ¼ 9) 0.078 (0.074-0.302) 0.899 (0.018-1.054) 0.232 (0.076-0.252) 0.255 (0.075-0.265) 1.020 (0.740-1.298)
Study groups
Middle-aged/control diet group
(n ¼ 11)
0.055 (0.029-0.100) 0.908 (0.466-1.031) 0.238 (0.227-0.257) 0.254 (0.136-0.387) 1.013 (0.867-1.674)
Middle-aged/high-fat diet group
(n ¼ 6)
0.077 (0.020-0.148) 0.722 (0.298-1.331) 0.197 (0.162-0.219) 0.198 (0.132-0.292) 1.219 (0.849-1.395)
Old/control diet group (n ¼ 9) 0.050 (0.030-0.118) 0.808 (0.594-0.993) 0.212 (0.191-0.230) 0.293 (0.193-0.360) 1.434 (0.808-1.670)
Old/high-fat diet group (n ¼ 7) 0.076 (0.048-0.086) 0.823 (0.329-1.029) 0.237 (0.184-0.259) 0.271 (0.102-0.309) 1.118 (0.972-1.439)
Kruskal-Wallisb Statistic, P 5.383, .250 1.045, .903 3.947, .413 4.244, .374 2.070, .723
Abbreviations: AIF1, allograft inflammatory factor-1; CAV3, caveolin-3; GFAP, glial fibrillary acidic protein; RBBP4, retinoblastoma binding protein-4 chromatin
remodeling factor.
aData are presented as median (interquartile range) in arbitrary unit.
bThe Kruskal-Wallis test is applied to all 5 groups (n ¼ 42).
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Focal Loss of Immunohistochemical Reactivity in the
Hippocampal Formation
Based on qualitative assessments in the hippocampal forma-
tion, we found focal loss of immunoreactivity for CAV3,
RBBP4, and GFAP in a pattern that spatially matched the
presence of dark neurons observed in the H&E-stained adja-
cent hemibrain sections (Figure 1). The spatial variation of
AIF1 immunoreactivity was not conspicuous in relation to
the presence of dark neurons in the hippocampal formation
(Figure 1).
Negative Correlations Between Dark Neuron
Hyperbasophilia and Immunohistochemical
Reactivity in the Hippocampal Formation
Based on quantitative image analyses in the hippocampal for-
mation, we found negative correlations between the hyperba-
sophilia density of dark neurons and the immunoreactivity
density of CAV3, RBBP4, and GFAP to be statistically
significant (r ¼ 0.444, 0.614, and 0.527; P ¼ .003, P <
.0001, and P ¼ .0003, respectively, n ¼ 42, Spearman rho;
Figure 2A-C). For AIF1 immunoreactivity, the correlation was
Figure 3. Representative images of the left hippocampal fimbria from young (3 months), middle-aged (14-15 months), and old (24-25 months)
male C57BL/6N mice (in rows of adjacent tissue sections). The diaminobenzidine immunohistochemistry for (A, C, and E) glial fibrillary acidic
protein (GFAP, astroglia) and (B, D, and F) allograft inflammatory factor-1 (AIF1, microglia) is depicted (original scan 20). Insets ¼ high
magnification (original scan 40).
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not statistically significant (r ¼ 0.246, P ¼ .116, n ¼ 42,
Spearman rho; Figure 2D).
No Difference in Dark Neuron Hyperbasophilia or
Immunohistochemical Reactivity in the Hippocampal
Formation Across Age/Diet Mouse Groups
In the hippocampal formation, we found no significant differ-
ence in median values of the hyperbasophilia density of dark
neurons or the immunoreactivity density of CAV3, RBBP4,
GFAP, or AIF1 across all 5 age/diet mouse groups (n ¼ 42,
Kruskal-Wallis test; Table 1).
Differences in Immunohistochemical Reactivity for GFAP
and AIF1 in the Hippocampal Fimbria Across Age/Diet
Mouse Groups
To compare the hippocampal formation affected by the occur-
rence of dark neurons with a neighboring white matter region in
regard to the immunohistochemical reactivity, we examined
GFAP and AIF1 immunoreactivity in the hippocampal fimbria
(Figure 3).
Across all 5 age/diet mouse groups, we found differences in
median values of the immunoreactivity density of GFAP and
AIF1 (P ¼ .020 and P < .0001, respectively, n ¼ 42, Kruskal-
Wallis test; Table 2). Compared with the baseline young/con-
trol diet group, the GFAP immunoreactivity density was higher
in the old/high-fat diet group (P < .05) but not significantly
higher in the other 3 study groups (Dunn multiple comparison
test; Figure 4A). Compared with the baseline young/control
diet group, the AIF1 immunoreactivity density was higher in
the old/control diet (P < .05) and old/high-fat diet (P < .01)
groups but not significantly higher in the other 2 study groups
(Dunn multiple comparison test; Figure 4B).
Discussion
As an incidental finding in our previous project studying the
effects of age and long-term high-fat diet exposure on meta-
bolic homeostasis in male C57BL/6N mice, we observed dark
neurons of varying density in the dorsal hippocampal formation
in a high proportion of mouse hemibrains from both study and
baseline groups. Based on quantitative image analysis, the
hyperbasophilia density of dark neurons (ie, dark neuron bur-
den) did not significantly differ among 5 age/diet mouse
Table 2. The Immunoreactivity Density of GFAP and AIF1 in the
Hippocampal Fimbria White Matter by Age/Diet Mouse Groups.a
GFAP AIF1
Baseline group
Young/control diet
(n ¼ 9)
0.542 (0.199-0.699) 1.527 (1.190-1.614)
Study groups
Middle-aged/control
diet (n ¼ 11)
0.726 (0.429-1.031) 1.405 (1.279-1.736)
Middle-aged/high-fat
diet (n ¼ 6)
0.464 (0.248-0.655) 1.363 (1.223-1.588)
Old/control diet (n ¼ 9) 0.892 (0.630-1.117) 2.304 (1.823-2.936)
Old/high-fat diet (n ¼ 7) 1.145 (0.413-1.473) 2.384 (2.182-3.185)
Kruskal-Wallisb Statistic, P 11.64, .020c 23.82, <.0001d
Abbreviations: AIF1, allograft inflammatory factor-1; GFAP, glial fibrillary acidic
protein.
aData are presented as median (interquartile range) in arbitrary unit.
bThe Kruskal-Wallis test is applied to all 5 groups (n ¼ 42).
cP < .05.
dP < .0001.
Figure 4. Box plots showing differences in the immunoreactivity
density of glial fibrillary acidic protein (GFAP) and allograft inflamma-
tory factor-1 (AIF1) in the left hippocampal fimbria among 5 age/diet
mouse groups. Data in each group are presented in arbitrary unit as a
box and whisker plot; X ¼ mean,  ¼ outlier. Compared with the
young/control diet group, the immunoreactivity density of GFAP (A)
was higher in the old/high-fat diet group and that of AIF1 (B) was
higher in the old/control diet and old/high-fat diet groups (Dunn mul-
tiple comparison test). *P < .05, **P < .01.
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groups. Accordingly, we interpreted that dark neurons in the
present study occurred in association with the mechanical han-
dling of fresh mouse brains prior to immersion fixation with
paraformaldehyde.4–6
Of note, we found focal loss of immunohistochemical reac-
tivity for CAV3, RBBP4, and GFAP in spatial association with
the presence of dark neurons in the hippocampal formation.
These qualitatively observed associations were confirmed by
our findings of negative correlations between the hyperbaso-
philia density of dark neurons and the immunoreactivity den-
sity of CAV3, RBBP4, and GFAP in the quantitative image
analysis. Furthermore, for each of protein markers examined,
we found no significant difference in the immunoreactivity
density in the hippocampal formation among 5 age/diet mouse
groups. On the other hand, in the hippocampal fimbria (a white
matter continuation of the hippocampal formation), there were
differences in the immunoreactivity density of GFAP and AIF1
among 5 age/diet mouse groups. That is, old age seemed to be
associated with the higher immunoreactivity density, in agree-
ment with previous studies showing aging-related increases in
GFAP and AIF1 expression in C57BL/6 mice.12,13 One poten-
tial explanation for these observations is the difference in tex-
ture of these 2 neuroanatomic structures with regard to the
handling-induced histological artifact, where the fimbria white
matter is less vulnerable to mechanical pressure applied to the
brain surface. Collectively, loss of immunohistochemical reac-
tivity for CAV3, RBBP4, and GFAP in the hippocampal for-
mation was likely a histological artifact associated with the
formation of handling-induced dark neurons.
Accumulating evidence suggests that handling-induced dark
neurons are formed as a result of pressure applied to living
fresh brains that are subsequently fixed with aldehydes.4–6 In
an experiment with rat cerebral cortex biopsy, the formation of
dark neurons could be prevented by pharmacologic blockage of
glutamate receptors.14 In addition, pathologically induced dark
neurons (ie, either reversibly or irreversibly injured neurons),
morphologically indistinguishable from handling-induced dark
neurons, were well documented in rodent brains that were ade-
quately perfusion-fixed with aldehydes following the experi-
mental induction of certain acute insults,5,6 such as status
epilepticus,15 hypoglycemia, and ischemic reperfusion
injury.16 Taken together, it is possible that the formation of
dark neurons of either handling or pathological origin repre-
sents an early-stage neuronal response to complete energy
deprivation and glutamate release, the perturbation that leads
to the cellular contraction at the time of fixation with
aldehydes.6
With regard to loss of immunohistochemical reactivity in
association with handling-induced dark neurons, it remains to
be explored in future studies as to how conformational changes
in protein molecules inherent to dark neurons16 could interfere
with the antigen–antibody interaction on immunohistochemis-
try. Note that our present study of immunohistochemical reac-
tivity alterations in association with handling-induced dark
neurons was based solely on 4 antibodies. This histological
artifact may or may not occur with other antibodies not tested
in our study. Moreover, our present finding may not be applied
to the context of dark neurons of pathological origin.17
In the current study, in addition to neuronal markers exam-
ined (CAV3 and RBBP4), the association between the presence
of dark neurons and loss of immunohistochemical reactivity for
an astroglial marker (GFAP) was unexpectedly observed. Our
findings suggest that the handling-induced histological artifact
resulting from pressure applied to fresh brains before being
fixed with aldehydes can interfere with the antigen–antibody
interaction on immunohistochemistry in astroglia as well.
In conclusion, our findings suggest that loss of immunohis-
tochemical reactivity can occur as an artifact associated with
the formation of handling-induced dark neurons. In experimen-
tal neuroscience research, if both histopathologic assessment
and molecular analysis are necessary, brain samples are to be
mechanically handled prior to fixation. In this scenario, the
brain should be handled gently and carefully to avoid the for-
mation of dark neurons.3 The unawareness of handling-induced
dark neurons, which are identifiable on bright-field H&E
microscopy, may lead to misinterpretation of immunohisto-
chemical reactivity alterations.5 In particular, this misinterpre-
tation may occur in the assessment of protein expression on
dark-field immunofluorescence microscopy of brain samples
that are not optimally handled during harvest and subsequently
fixed with aldehydes and in which histopathologic changes are
not concurrently evaluated on bright-field microscopy.
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